Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC23227189;7190;7191 chr2:178774300;178774299;178774298chr2:179639027;179639026;179639025
N2AB23227189;7190;7191 chr2:178774300;178774299;178774298chr2:179639027;179639026;179639025
N2A23227189;7190;7191 chr2:178774300;178774299;178774298chr2:179639027;179639026;179639025
N2B22767051;7052;7053 chr2:178774300;178774299;178774298chr2:179639027;179639026;179639025
Novex-122767051;7052;7053 chr2:178774300;178774299;178774298chr2:179639027;179639026;179639025
Novex-222767051;7052;7053 chr2:178774300;178774299;178774298chr2:179639027;179639026;179639025
Novex-323227189;7190;7191 chr2:178774300;178774299;178774298chr2:179639027;179639026;179639025

Information

  • RefSeq wild type amino acid: N
  • RefSeq wild type transcript codon: AAC
  • RefSeq wild type template codon: TTG
  • Domain: Ig-12
  • Domain position: 56
  • Structural Position: 137
  • Q(SASA): 0.1647
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
N/I rs1283394684 0.228 0.006 N 0.522 0.343 0.438806408302 gnomAD-2.1.1 3.98E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.82E-06 0
N/I rs1283394684 0.228 0.006 N 0.522 0.343 0.438806408302 gnomAD-4.0.0 1.59057E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85675E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
N/A 0.1708 likely_benign 0.1762 benign -0.97 Destabilizing 0.176 N 0.487 neutral None None None None N
N/C 0.2155 likely_benign 0.2242 benign -0.452 Destabilizing 0.981 D 0.588 neutral None None None None N
N/D 0.2477 likely_benign 0.2556 benign -1.836 Destabilizing 0.425 N 0.415 neutral N 0.477922482 None None N
N/E 0.4239 ambiguous 0.4457 ambiguous -1.61 Destabilizing 0.495 N 0.403 neutral None None None None N
N/F 0.2839 likely_benign 0.2953 benign -0.612 Destabilizing 0.893 D 0.62 neutral None None None None N
N/G 0.2898 likely_benign 0.2968 benign -1.363 Destabilizing 0.495 N 0.397 neutral None None None None N
N/H 0.1073 likely_benign 0.1086 benign -1.026 Destabilizing 0.975 D 0.559 neutral N 0.442889034 None None N
N/I 0.0777 likely_benign 0.0793 benign 0.069 Stabilizing 0.006 N 0.522 neutral N 0.395043653 None None N
N/K 0.2892 likely_benign 0.3145 benign -0.166 Destabilizing 0.425 N 0.408 neutral N 0.288038055 None None N
N/L 0.1312 likely_benign 0.1384 benign 0.069 Stabilizing 0.329 N 0.509 neutral None None None None N
N/M 0.1645 likely_benign 0.1687 benign 0.265 Stabilizing 0.893 D 0.563 neutral None None None None N
N/P 0.9303 likely_pathogenic 0.9366 pathogenic -0.25 Destabilizing 0.828 D 0.577 neutral None None None None N
N/Q 0.2953 likely_benign 0.3126 benign -0.824 Destabilizing 0.828 D 0.522 neutral None None None None N
N/R 0.3407 ambiguous 0.3738 ambiguous -0.396 Destabilizing 0.828 D 0.48 neutral None None None None N
N/S 0.0835 likely_benign 0.0838 benign -1.129 Destabilizing 0.029 N 0.231 neutral N 0.305676661 None None N
N/T 0.0811 likely_benign 0.0847 benign -0.717 Destabilizing 0.003 N 0.171 neutral N 0.36293696 None None N
N/V 0.1063 likely_benign 0.1083 benign -0.25 Destabilizing 0.329 N 0.511 neutral None None None None N
N/W 0.663 likely_pathogenic 0.686 pathogenic -0.569 Destabilizing 0.995 D 0.618 neutral None None None None N
N/Y 0.1081 likely_benign 0.1111 benign -0.178 Destabilizing 0.975 D 0.573 neutral N 0.418439716 None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.